Edwards Lifesciences (NYSE: EW) today announced new scientific evidence presented and published during the American College of Cardiology's (ACC) Annual
Edwards is a California-based medical device firm that develops and supplies products such as transcatheter heart valves and pressure transducers for the healthcare industry.